Site Selection magazine
twitter linkedIn facebook email email
TRANSLATE: 
i
  MEDICAL DEVICES 
Medical device industry supplier Helix Medical follows its customers to Central America. Hear why from the CEO, in Close Counts.

 HEALTHCARE   
A new campus from the mother of all medical centers could be a leading indicator for Houston, in Tex Med Goes West.

 BIOTECH   
Biopharma firm Astellas Pharma undertakes two major expansion projects in two major metros, in Ready for Growth.

 BRIEFLY BIO 

The University of California, San Francisco, has opened a new stem cell research center. It will be home to one of the most comprehensive programs in the U.S. The $123-million building was paid for with state and private funds.

Copyright Bruce Damonte/Courtesy of Rafael Vinoly Architects

The Advanced Medical Technology Association (AdvaMed) has released a statement supporting the introduction of the Innovate America Act. AdvaMed says the act includes provisions that will promote industries including medical technology.


Green buildings are in, as life sciences buildings are increasingly qualifying for LEED certification. A recent example is the Marine Biological Laboratory's newly renovated Loeb Laboratory in Woods Hole, Mass.

Photo courtesy of the Marine Biological Laboratory

Six pharmaceutical manufacturing facilities constructed in Europe and the U.S. have been selected as category winners in the seventh annual Facility of the Year Awards (FOYA) program sponsored by ISPE (International Society for Pharmaceutical Engineering), INTERPHEX [drug and drug delivery exhibition], and Pharmaceutical Processing magazine.


The Massachusetts Life Sciences Center says that half of the companies that received tax incentives in the state during 2010 did not meet job creation goals.


Minnesota has improved the competitiveness of its bioscience sector in recent years, according to a new study which also highlights areas of future opportunity for the state.


A new report by BIO and the Ipreo research organization says that investors are optimistic about biotech's future. The study gathered feedback from 135 investment professionals representing firms with $2 trillion in equity assets under management

Vol.2 , Issue 02

 
i
Connect with Site Selection
twitter twitter email linkedIn


Most Popular Articles









Site Selection online is a worldwide service of Conway, Inc. ©1983-2018, all rights reserved.
Data is from many sources and not warranted to be accurate or current.
For contact information visit our staff page or send general information queries to Cathie Wendt.
Send direct technical inquiries or comments to webmaster bounce@conway.com. View our Privacy Policy.
HOME | SITE SELECTION MAGAZINE ARCHIVES | SUBSCRIBE